Jubilant Pharmova informs about credit rating

27 Dec 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that India Ratings and Research has assigned Long-term issuer rating of ‘IND AA+’ Rating for the company. The instrument-wise ratings are enclosed. The Company has received the rating letter from India Ratings and Research on December 26, 2022.

The above information is a part of company’s filings submitted to BSE.


Jubilant Pharmova Share Price

1074.30 7.05 (0.66%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×